Multinationals, institutions and agency : a study of the Russian pharmaceutical sector

It has been previously acknowledged that multinational corporations (MNCs) are powerful actors that possess and leverage human resources, capital, technology and knowledge across national boundaries for corporate advantage. Despite the promise of this analytical context, understanding of the work of...

Full description

Bibliographic Details
Main Author: Jacob, Dimitry
Published: Queen's University Belfast 2017
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.727405
id ndltd-bl.uk-oai-ethos.bl.uk-727405
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-7274052017-12-24T16:52:15ZMultinationals, institutions and agency : a study of the Russian pharmaceutical sectorJacob, Dimitry2017It has been previously acknowledged that multinational corporations (MNCs) are powerful actors that possess and leverage human resources, capital, technology and knowledge across national boundaries for corporate advantage. Despite the promise of this analytical context, understanding of the work of agency by MNCs remains limited. This thesis therefore aims to understand the work of agency in producing institutional change within a host market setting. To do so, a study of the Russian pharmaceutical sector is undertaken and it draws upon 107 interviews with 46 managers representing 26 pharmaceutical MNCs, 4 heads of associations of pharmaceutical manufacturers and 2 independent Pharma experts. This thesis frames agency as ontologically temporal, whereby actors express different capacity for agency and engage institutions differently when their actions relate to past, future, or present time. The findings also show that the participation and contribution of multiple actors is required in order to enact change. This agentic work becomes evident first, as a multi-profile phenomenon whereby social action is denoted by the inter-permeation between micro (organisational) and meso (inter- organisational) linked efforts. Second, as the internal composition of agency comprising embedded processes of re-orientation towards past, future or present times, re-formulation of iterative, projective and practical - evaluative expression of action, and re-engagement of institutions with efforts to maintain, to create and/or to disrupt national institutions. Finally, agency is manifested in linking mechanisms working across micro- and meso-levels of agency to produce institutional change. The overall findings lead to elaboration of instantiation of multinational agency through multiple instances of agency that assume different levels of intent, self-interest and capacity for action. As such, this thesis contributes to the literature on inter-relations between institutions and agency and specifically, advances the literature on micro-foundationa, institutionalism.338.4Queen's University Belfasthttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.727405Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 338.4
spellingShingle 338.4
Jacob, Dimitry
Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
description It has been previously acknowledged that multinational corporations (MNCs) are powerful actors that possess and leverage human resources, capital, technology and knowledge across national boundaries for corporate advantage. Despite the promise of this analytical context, understanding of the work of agency by MNCs remains limited. This thesis therefore aims to understand the work of agency in producing institutional change within a host market setting. To do so, a study of the Russian pharmaceutical sector is undertaken and it draws upon 107 interviews with 46 managers representing 26 pharmaceutical MNCs, 4 heads of associations of pharmaceutical manufacturers and 2 independent Pharma experts. This thesis frames agency as ontologically temporal, whereby actors express different capacity for agency and engage institutions differently when their actions relate to past, future, or present time. The findings also show that the participation and contribution of multiple actors is required in order to enact change. This agentic work becomes evident first, as a multi-profile phenomenon whereby social action is denoted by the inter-permeation between micro (organisational) and meso (inter- organisational) linked efforts. Second, as the internal composition of agency comprising embedded processes of re-orientation towards past, future or present times, re-formulation of iterative, projective and practical - evaluative expression of action, and re-engagement of institutions with efforts to maintain, to create and/or to disrupt national institutions. Finally, agency is manifested in linking mechanisms working across micro- and meso-levels of agency to produce institutional change. The overall findings lead to elaboration of instantiation of multinational agency through multiple instances of agency that assume different levels of intent, self-interest and capacity for action. As such, this thesis contributes to the literature on inter-relations between institutions and agency and specifically, advances the literature on micro-foundationa, institutionalism.
author Jacob, Dimitry
author_facet Jacob, Dimitry
author_sort Jacob, Dimitry
title Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
title_short Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
title_full Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
title_fullStr Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
title_full_unstemmed Multinationals, institutions and agency : a study of the Russian pharmaceutical sector
title_sort multinationals, institutions and agency : a study of the russian pharmaceutical sector
publisher Queen's University Belfast
publishDate 2017
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.727405
work_keys_str_mv AT jacobdimitry multinationalsinstitutionsandagencyastudyoftherussianpharmaceuticalsector
_version_ 1718580566408822784